This acute-phase reactant is secreted by the liver in the setting of infection, inflammation or tissue damage. [16] Studies have shown that in patients with stable COPD, CRP levels are directly ...

Also, unlike other components of the alternative pathway, MASP-3 is believed not to be an acute phase reactant, which could provide a significant advantage to MASP-3 inhibitors, like zaltenibart ...